Literature DB >> 11165437

Effects of intrahippocampal aniracetam treatment on Y-maze avoidance learning performance and behavioral long-term potentiation in dentate gyrus in rat.

Y Rao1, P Xiao, S Xu.   

Abstract

Effects of intrahippocampal treatment of aniracetam, a selective agonist for DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproionic acid (AMPA) receptors, on Y-maze avoidance learning task and behavioral long-term potentiation (LTP) in perforant path-dentate gyrus were studied in freely moving rats by using in vivo electrophysiology combined with behavioral tests. The results were as follows: (1) intrahippocampal treatment of aniracetam reversibly enhanced basal synaptic transmission in perforant path to dentate gyrus in a dosage dependent manner; (2) aniracetam produced improvement in Y-maze learning performance when administration occurred 5 min prior to maze learning; (3) aniracetam administration significantly facilitated behavioral LTP in dentate gyrus, while the maximal amplitude of LTP has no significant difference when compared to saline group. The present results indicate that hippocampal AMPA receptors are involved in learning and memory.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165437     DOI: 10.1016/s0304-3940(00)01744-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats.

Authors:  Hong Yu Xue; Ya Nan Lu; Xue Mei Fang; Yong Ping Xu; Gui Zhen Gao; Li Ji Jin
Journal:  Mol Biol Rep       Date:  2012-07-19       Impact factor: 2.316

Review 2.  Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.

Authors:  Mark D Black
Journal:  Psychopharmacology (Berl)       Date:  2005-01-26       Impact factor: 4.530

Review 3.  Neuroprotective Effects and Mechanisms of Senegenin, an Effective Compound Originated From the Roots of Polygala Tenuifolia.

Authors:  Zhe Chen; Yu Yang; Ying Han; Xijun Wang
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

4.  Potentiation of amygdala AMPA receptor activity selectively promotes escalated alcohol self-administration in a CaMKII-dependent manner.

Authors:  Reginald Cannady; Kristen R Fisher; Caitlin Graham; Jesse Crayle; Joyce Besheer; Clyde W Hodge
Journal:  Addict Biol       Date:  2016-01-06       Impact factor: 4.280

5.  Participation of hippocampal ionotropic glutamate receptors in histamine H(1) antagonist-induced memory deficit in rats.

Authors:  Takayoshi Masuoka; Shunsuke Saito; Chiaki Kamei
Journal:  Psychopharmacology (Berl)       Date:  2007-12-07       Impact factor: 4.530

6.  Oral aniracetam treatment in C57BL/6J mice without pre-existing cognitive dysfunction reveals no changes in learning, memory, anxiety or stereotypy.

Authors:  Conner D Reynolds; Taylor S Jefferson; Meagan Volquardsen; Ashvini Pandian; Gregory D Smith; Andrew J Holley; Joaquin N Lugo
Journal:  F1000Res       Date:  2017-08-14

Review 7.  Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline.

Authors:  Adejoke Yetunde Onaolapo; Adebimpe Yemisi Obelawo; Olakunle James Onaolapo
Journal:  Curr Aging Sci       Date:  2019

8.  Aniracetam does not alter cognitive and affective behavior in adult C57BL/6J mice.

Authors:  Thomas W Elston; Ashvini Pandian; Gregory D Smith; Andrew J Holley; Nanjing Gao; Joaquin N Lugo
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

9.  Effects of Modafinil on Behavioral Learning and Hippocampal Synaptic Transmission in Rats.

Authors:  Wen-Wen Yan; Li-Hua Yao; Chong Chen; Hai-Xia Wang; Chu-Hua Li; Jun-Ni Huang; Peng Xiao; Cheng-Yi Liu
Journal:  Int Neurourol J       Date:  2015-12-28       Impact factor: 2.835

Review 10.  Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.

Authors:  Noor Azuin Suliman; Che Norma Mat Taib; Mohamad Aris Mohd Moklas; Mohd Ilham Adenan; Mohamad Taufik Hidayat Baharuldin; Rusliza Basir
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-30       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.